Telehealth weight-loss programmes

The common shape: an online intake, a clinician review, a prescription if appropriate, delivery from a partner pharmacy, and some level of ongoing check-in. Programmes differ enormously in how much clinical substance sits behind each of those steps.

At one end, a service orders laboratory work, reviews your history properly, has a named clinician you can speak to, and monitors you over time. At the other, an intake form is reviewed briefly and a subscription begins.

Both are legal. They are not equivalent, and the price difference between them is frequently small.

• Will a licensed clinician review my history, and can I find out who they are and where they are licensed?
• Is any laboratory work ordered before prescribing?
• Is the medication branded or compounded — and if compounded, which pharmacy and under what authority?
• What monitoring happens after I start, and how often?
• What is the process if I have a side effect — who do I actually reach, and how quickly?
• Is there a path where the answer is no, this is not appropriate for you?
• What is the total monthly cost after any introductory period, and what is the commitment?

The side-effect question is the most revealing one. A programme built as a clinical service has a clear answer. A programme built as a storefront usually points you at a support inbox.

Most run on a flat monthly subscription that bundles the consultation, the medication and some support. Watch for what sits outside it — laboratory work, follow-up consultations, and what the introductory rate becomes.

Many operate outside insurance networks entirely, which means the subscription is not reimbursable even where your plan would have covered the medication. If you have coverage, check whether an in-network route exists before signing up for a cash programme.

This is the part worth reading before you hand over a card, and it is not our list — FDA publishes telehealth warning signs for consumers specifically in connection with GLP-1 medicines. A company showing several of these is telling you what it is.

• Claims that a compounded drug is the same as an FDA-approved drug. It is not, and a service saying otherwise is either confused or misleading you.
• Medicine offered at deep discounts, or at prices that seem too good to be true.
• Medicine that arrives looking different from what you previously received or from what was pictured, or in packaging that is damaged or missing instructions for use.
• No screening and no prescription by a licensed doctor before medicine is supplied.
• No licensed doctor available to answer questions after you receive the medication.
• Spelling errors on the label, or incorrect pharmacy addresses.
• A pharmacy name on the label that you cannot verify.

Two related points from the same source. Injectable GLP-1 products require refrigeration per their package inserts, and FDA advises against using any that arrives warm or with inadequate ice packs. And the agency has documented fraudulent compounded product carrying pharmacy names that do not exist, or names of real pharmacies that did not make it — so the label is worth checking rather than assuming.

Check your plan first. The single most common expensive mistake here is paying cash for a programme when the branded medication was covered under an in-network prescriber all along.

Dosing is determined by a licensed provider.

How we verify providers

• FDA — FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — retrieved 2026-08-06
• FDA — FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize — retrieved 2026-08-06